Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report)’s share price fell 6.8% during trading on Monday . The company traded as low as $1.02 and last traded at $1.03. 2,726,105 shares were traded during trading, a decline of 67% from the average session volume of 8,242,699 shares. The stock had previously closed at $1.10.
Clover Health Investments Stock Down 10.4 %
The company has a market cap of $489.24 million, a P/E ratio of -2.90 and a beta of 2.09. The business has a fifty day moving average of $0.83 and a 200 day moving average of $0.89.
Clover Health Investments (NASDAQ:CLOV – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.02. The company had revenue of $346.92 million during the quarter, compared to the consensus estimate of $316.10 million. Clover Health Investments had a negative return on equity of 48.07% and a negative net margin of 8.63%. On average, sell-side analysts anticipate that Clover Health Investments, Corp. will post -0.21 EPS for the current fiscal year.
Insider Activity at Clover Health Investments
In other news, Director Anna U. Loengard acquired 137,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was acquired at an average price of $0.73 per share, for a total transaction of $100,010.00. Following the completion of the acquisition, the director now owns 538,841 shares in the company, valued at $393,353.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 22.28% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Clover Health Investments
A number of institutional investors have recently added to or reduced their stakes in the company. Jaffetilchin Investment Partners LLC grew its stake in shares of Clover Health Investments by 30.2% in the first quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock worth $39,000 after acquiring an additional 11,550 shares during the last quarter. Swiss National Bank grew its stake in shares of Clover Health Investments by 1.6% in the third quarter. Swiss National Bank now owns 782,200 shares of the company’s stock worth $845,000 after acquiring an additional 12,400 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Clover Health Investments by 2.6% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 813,695 shares of the company’s stock worth $879,000 after acquiring an additional 20,813 shares during the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Clover Health Investments during the third quarter valued at $25,000. Finally, Rathbones Group PLC purchased a new stake in shares of Clover Health Investments during the third quarter valued at $27,000. Institutional investors own 19.77% of the company’s stock.
Clover Health Investments Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.